624 related articles for article (PubMed ID: 15995512)
1. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
[TBL] [Abstract][Full Text] [Related]
2. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
3. Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia.
Aviv JE; Liu H; Parides M; Kaplan ST; Close LG
Ann Otol Rhinol Laryngol; 2000 Nov; 109(11):1000-6. PubMed ID: 11089989
[TBL] [Abstract][Full Text] [Related]
4. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
Bilgen C; Ogüt F; Kesimli-Dinç H; Kirazli T; Bor S
J Laryngol Otol; 2003 May; 117(5):386-90. PubMed ID: 12803789
[TBL] [Abstract][Full Text] [Related]
5. Rethinking the laryngopharyngeal reflux treatment algorithm: Evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease.
Carroll TL; Werner A; Nahikian K; Dezube A; Roth DF
Laryngoscope; 2017 Oct; 127 Suppl 6():S1-S13. PubMed ID: 28842999
[TBL] [Abstract][Full Text] [Related]
6. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320
[TBL] [Abstract][Full Text] [Related]
7. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
[TBL] [Abstract][Full Text] [Related]
8. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
[TBL] [Abstract][Full Text] [Related]
9. Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Belafsky PC; Postma GN; Koufman JA
Laryngoscope; 2001 Jun; 111(6):979-81. PubMed ID: 11404607
[TBL] [Abstract][Full Text] [Related]
10. Composite pH predicts esomeprazole response in laryngopharyngeal reflux without typical reflux syndrome.
Lien HC; Wang CC; Liang WM; Sung FC; Hsu JY; Yeh HZ; Chong K; Chang CS
Laryngoscope; 2013 Jun; 123(6):1483-9. PubMed ID: 23553459
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
12. Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux.
Qadeer MA; Swoger J; Milstein C; Hicks DM; Ponsky J; Richter JE; Abelson TI; Vaezi MF
Laryngoscope; 2005 Nov; 115(11):1947-52. PubMed ID: 16319603
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.
Reichel O; Dressel H; Wiederänders K; Issing WJ
Otolaryngol Head Neck Surg; 2008 Sep; 139(3):414-20. PubMed ID: 18722223
[TBL] [Abstract][Full Text] [Related]
14. Empiric esomeprazole in the treatment of laryngopharyngeal reflux.
DelGaudio JM; Waring JP
Laryngoscope; 2003 Apr; 113(4):598-601. PubMed ID: 12671413
[TBL] [Abstract][Full Text] [Related]
15. Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders.
Monini S; Di Stadio A; Vestri A; Barbara M
Acta Otolaryngol; 2006 Aug; 126(8):866-71. PubMed ID: 16846931
[TBL] [Abstract][Full Text] [Related]
16. Acid reflux management: ENT perspective.
Ahmad I; Batch AJ
J Laryngol Otol; 2004 Jan; 118(1):25-30. PubMed ID: 14979968
[TBL] [Abstract][Full Text] [Related]
17. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study.
Swoger J; Ponsky J; Hicks DM; Richter JE; Abelson TI; Milstein C; Qadeer MA; Vaezi MF
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):433-41. PubMed ID: 16616347
[TBL] [Abstract][Full Text] [Related]
18. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
Katzka DA; Paoletti V; Leite L; Castell DO
Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
Wo JM; Koopman J; Harrell SP; Parker K; Winstead W; Lentsch E
Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
[TBL] [Abstract][Full Text] [Related]
20. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
Johnsson F; Hatlebakk JG; Klintenberg AC; Román J; Toth E; Stubberöd A; Falk A; Edin R
Scand J Gastroenterol; 2003 Apr; 38(4):354-9. PubMed ID: 12739706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
